Oncogenes y Dianas Efectoras
PANCCUN
![Foto de Oncogenes y Dianas Efectoras](/img/uploaded/cfbefccdba02742414c74e77b99a3a7b.jpg)
![Foto de Massachusetts General Hospital](/img/noimage_org.png)
Massachusetts General Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts General Hospital (1)
2022
-
Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
European Journal of Cancer, Vol. 174, pp. S116